Filip Van den Bosch, MD

Filip Van den Bosch is Head-of-Clinic and Associate Professor of Rheumatology in the Department of Rheumatology at the University Hospital of Ghent University. The department has a long history of performing clinical and basic research, linking inflammatory bowel disease to the different rheumatological entities belonging to the spondyloarthritis concept. The department has been cited continuously as a Centre of Excellence in Rheumatology by EULAR since 2006. Dr Van den Bosch graduated in medicine at the University of Ghent, Belgium in 1991; he became board certified in rheumatology in 1996 and received a PhD degree in 2003, with his doctoral thesis focusing on the exploration of the therapeutic potential of TNF-alpha blockade in spondyloarthritis patients and more specifically in patients with bowel-related arthritis. He serves as an executive committee member of the ‘Assessments in SpondyloArthritis International Society’ (ASAS); he is also a member of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). His main interests are in clinical research. Dr Van den Bosch has been an investigator in several international or investigator-initiated clinical trials and mechanism-of-action studies in the areas of rheumatoid arthritis, osteoarthritis and especially the diseases belonging to the spondyloarthritis concept. He is the author or co-author of more than 100 peer-reviewed international publications and chapters in textbooks.